PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch

With a street-high upside potential of 109.4%, PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the 10 best robotics stocks to buy under $30. PROCEPT BioRobotics Corporation (NASDAQ:PRCT) has had a productive stretch heading into mid-2026, with two developments that together strengthen both the clinical and commercial case for Aquablation therapy. The first arrived on March 23, [...]